Point‐Of‐Care Ultra‐Portable Single‐Molecule Bioassays for One‐Health (Adv. Mater. 13/2024)

Eleonora Macchia,Fabrizio Torricelli,Mariapia Caputo,Lucia Sarcina,Cecilia Scandurra,Paolo Bollella,Michele Catacchio,Matteo Piscitelli,Cinzia Di Franco,Gaetano Scamarcio,Luisa Torsi
DOI: https://doi.org/10.1002/adma.202470094
IF: 29.4
2024-03-30
Advanced Materials
Abstract:Preventing Healthcare In article number 2309705 by Luisa Torsi and co‐workers, CRISPR strip tests and SiMoT bioelectronic devices, are reviewed as highly effective point‐of‐care technologies. They possess the unique capability to assay single molecules at concentrations of 10−20 molar, coupled with exceptional reliability, demonstrating diagnostic sensitivity and selectivity exceeding 95–99%. An androgynous humanoid is holding the palmar device, which can be used in a wide range of One Health applications.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?